The relationship between SREBP2 and AD has been explained previously, and the knockdown of SREBP1 has been reported to reduce the palmitate-induced increase in BACE1 expression and subsequent Aβ genesis in the mouse hippocampus and mouse Neuro-2a neuroblastoma cells [166]. Here, SREBF2 is linked to Alzheimer disease.